Table 3.

Markers to identify B cells subsets

B cell subsets	Immunophenotype	References
B1 B cells	CD19+CD27+CD43+	Griffin DO et.al[1, 2], Torring C et.al[3], Inui M et.al[4]
B2 B cells	CD19+CD23+ CD27-CD43-	Griffin DO et.al[1], Deng C et.al[5]
Transitional B cells	CD19+CD38hiCD24hi	Marie-Cardine A et.al[6], Ha Y et.al[7], Seifert M et.al[8], de Masson A et.al[9], Cherukuri A et.al[10], Heidt S et.al[11], Latorre I et.al[12], Tebbe B et.al[13], Luk F et.al[14], Demoersman J et.al[15], Li S et.al[16]
Naïve B cells	CD19+CD27-IgD+	Guerreiro-Cacais A et.al[17], So N et.al[18], Heath E et.al[19], Cantaert T et.al[20], Toapanta F et.al[21], Jansen M et.al[22], Castaneda D et.al[23], Wu X et.al[24], Nakayama Y et.al[25]
Class-switched memory B cells	CD19+CD27+IgD-	Anolik J et.al[26], Tian C et.al[27], Ghannam A et.al[28], Palanichamy A et.al[29], Berkowska M et.al[30], Morbach H et.al[31], Wu Y et.al[32], So N et.al[18], Heath E et.al[19], Topanta F et.al[21], Labuda L et.al[33], Degauque N et.al[34], Zhang L et.al[35], Bagnara D et.al[36], Czarnowicki T et.al[37], Hayashi M et.al[38], Mensah F et.al[39], Woda M et.al[40], Castaneda D et.al[23], Martins C et.al[41]
Non class-switched memory B cells	CD19+CD27+IgD+	Anolik J et.al[26], Tian C et.al[27], Palanichamy A et.al[29], Colonna-Romano G et.al[42], Jacobi A et.al[43], Wu Y et.al[32], So N et.al[18], Heath E et.al[19], Topanta F et.al[21], Weller S et.al[44], Labuda LA et.al[33], Clemente A et.al[45], Czarnowicki T et.al[37], Mensah F et.al[39], Castaneda D et.al[23], Martins C et.al[41], Corneth O et.al[46], Torigoe M et.al[47], Hu F, et.al[48]
Plasmablasts	CD19+CD20-CD38+CD24-	Morbach H et.al[49], Lin W et.al[50], Benett M et.al[51]

References

^1.Griffin, D.O., N.E. Holodick, and T.L. Rothstein, Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med, 2011. 208(1): p. 67–80.

^2.Griffin, D.O. and T.L. Rothstein, A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus. J Exp Med, 2011. 208(13): p. 2591–8.

^3.Torring, C., et al., The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis. J Neuroimmunol, 2013. 262(1–2): p. 92–9.

^4.Inui, M., et al., Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol, 2015. 27(7): p. 345–55.

^5.Deng, C., et al., The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status. J Diabetes Res, 2017. 2017: p. 5052812.

^6.Marie-Cardine, A., et al., Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol, 2008. 127(1): p. 14–25.

^7.Ha, Y.J., et al., Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells. J Leukoc Biol, 2008. 84(6): p. 1557–64.

^8.Seifert, M., et al., Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med, 2012. 209(12): p. 2183–98.

^9.de Masson, A., H. Le Buanec, and J.D. Bouaziz, Purification and immunophenotypic characterization of human B cells with regulatory functions. Methods Mol Biol, 2014. 1190: p. 45–52.

^10.Cherukuri, A., et al., Immunologic human renal allograft injury associates with an altered IL-10/TNF-alpha expression ratio in regulatory B cells. J Am Soc Nephrol, 2014. 25(7): p. 1575–85.

^11.Heidt, S., et al., B Cell Markers of Operational Tolerance Can Discriminate Acute Kidney Allograft Rejection From Stable Graft Function. Transplantation, 2015. 99(5): p. 1058–1064.

^12.Latorre, I., et al., Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients. Transpl Immunol, 2016. 35: p. 1–6.

^13.Tebbe, B., et al., Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19+CD24hiCD38hi Regulatory B-Lymphocytes. PLoS One, 2016. 11(4): p. e0153170.

^14.Luk, F., et al., Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function. Front Immunol, 2017. 8: p. 1042.

^15.Demoersman, J., et al., B cell subset distribution is altered in patients with severe periodontitis. PLoS One, 2018. 13(2): p. e0192986.

^16.Li, S., et al., Marked elevation of circulating CD19(+)CD38(hi)CD24(hi) transitional B cells give protection against neonatal sepsis. Pediatr Neonatol, 2018. 59(3): p. 296–304.

^17.Guerreiro-Cacais, A.O., J. Levitskaya, and V. Levitsky, B cell receptor triggering sensitizes human B cells to TRAIL-induced apoptosis. J Leukoc Biol, 2010. 88(5): p. 937–45.

^18.So, N.S., M.A. Ostrowski, and S.D. Gray-Owen, Vigorous response of human innate functioning IgM memory B cells upon infection by Neisseria gonorrhoeae. J Immunol, 2012. 188(8): p. 4008–22.

^19.Heath, E., et al., Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog, 2012. 8(5): p. e1002697.

^20.Cantaert, T., et al., Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis. Arthritis Rheum, 2012. 64(6): p. 1859–68.

^21.Toapanta, F.R., P.J. Bernal, and M.B. Sztein, Diverse phosphorylation patterns of B cell receptor-associated signaling in naive and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level. Front Cell Infect Microbiol, 2012. 2: p. 128.

^22.Jansen, M.A., et al., Decreased memory B cells and increased CD8 memory T cells in blood of breastfed children: the generation R study. PLoS One, 2015. 10(5): p. e0126019.

^23.Castaneda, D.M., D.M. Salgado, and C.F. Narvaez, B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue. Virology, 2016. 497: p. 136–145.

^24.Wu, X., et al., Impaired T Cell-dependent Humoral Immune Response Associated with Juvenile-onset Recurrent Respiratory Papillomatosis Progression. Sci Rep, 2016. 6: p. 36378.

^25.Nakayama, Y., et al., Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity. J Immunol, 2017. 199(7): p. 2388–2407.

^26.Anolik, J.H., et al., Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol, 2008. 180(2): p. 688–92.

^27.Tian, C., et al., Immunodominance of the VH1–46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J Immunol, 2008. 180(5): p. 3279–88.

^28.Ghannam, A., et al., Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells. J Immunol, 2008. 181(7): p. 5158–66.

^29.Palanichamy, A., et al., Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol, 2009. 182(10): p. 5982–93.

^30.Berkowska, M.A., et al., Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood, 2011. 118(8): p. 2150–8.

^31.Morbach, H., et al., Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis. Arthritis Rheum, 2011. 63(11): p. 3458–66.

^32.Wu, Y.C., D. Kipling, and D.K. Dunn-Walters, The relationship between CD27 negative and positive B cell populations in human peripheral blood. Front Immunol, 2011. 2: p. 81.

^33.Labuda, L.A., et al., Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis. PLoS Negl Trop Dis, 2013. 7(3): p. e2094.

^34.Degauque, N., et al., Characterization of antigen-specific B cells using nominal antigen-coated flow-beads. PLoS One, 2013. 8(12): p. e84273.

^35.Zhang, L., et al., Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis. J Virol, 2014. 88(19): p. 11430–41.

^36.Bagnara, D., et al., A Reassessment of IgM Memory Subsets in Humans. J Immunol, 2015. 195(8): p. 3716–24.

^37.Czarnowicki, T., et al., Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis. J Allergy Clin Immunol, 2016. 137(1): p. 118–129 e5.

^38.Hayashi, M., et al., IL-10-producing regulatory B cells are decreased in patients with psoriasis. J Dermatol Sci, 2016. 81(2): p. 93–100.

^39.Mensah, F., et al., Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Clin Exp Immunol, 2016. 184(2): p. 237–47.

^40.Woda, M., et al., Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions. J Infect Dis, 2016. 214(7): p. 1001–9.

^41.Martins, C., et al., Pregnancy alters the circulating B cell compartment in atopic asthmatic women, and transitional B cells are positively associated with the development of allergy manifestations in their progeny. Am J Reprod Immunol, 2016. 76(6): p. 465–474.

^42.Colonna-Romano, G., et al., A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech Ageing Dev, 2009. 130(10): p. 681–90.

^43.Jacobi, A.M., et al., Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum, 2010. 62(1): p. 201–10.

^44.Weller, S., et al., IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients. Blood, 2012. 120(25): p. 4992–5001.

^45.Clemente, A., et al., Increased STAT3 phosphorylation on CD27(+) B-cells from common variable immunodeficiency disease patients. Clin Immunol, 2015. 161(2): p. 77–88.

^46.Corneth, O.B.J., et al., Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease. Arthritis Rheumatol, 2017. 69(6): p. 1313–1324.

^47.Torigoe, M., et al., Metabolic Reprogramming Commits Differentiation of Human CD27(+)IgD(+) B Cells to Plasmablasts or CD27(-)IgD(-) Cells. J Immunol, 2017. 199(2): p. 425–434.

^48.Hu, F., et al., Impaired CD27(+)IgD(+) B Cells With Altered Gene Signature in Rheumatoid Arthritis. Front Immunol, 2018. 9: p. 626.

^49.Morbach, H., et al., Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol, 2010. 162(2): p. 271–9.

^50.Lin, W., et al., Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease. Arthritis Res Ther, 2017. 19(1): p. 25.

^51.Bennett, M.S., et al., Human mucosal-associated invariant T (MAIT) cells possess capacity for B cell help. J Leukoc Biol, 2017. 102(5): p. 1261–1269.